Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Global Hemostats Market is accounted to reach USD 4.5 billion by 2024 from USD 2.7 billion in 2016, at a CAGR of 6.6% in the forecast period 2017 to 2024.
The major factors driving the growth of this market are the increasing number of surgeries, increasing healthcare expenditure, technological advancements, chronic condition and aging population.
The key market players for Global Medical Aesthetics Market are listed below:
• Ethicon US LLC (U.S.)
• Pfizer and C.R. Bard Inc.,
• Baxter,
• Vascular Solutions, Inc.,
• B.Braun Melsungen,
• 3-D Matrix, Ltd.,
• Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
• , Anika Therapeutics, Inc.,
• Arch Therapeutics Inc.
• , Biom’Up SAS,
• CryoLife, Inc.,
• Gamma Therapeutics, Inc.,
• Hemostasis,
• LLC,
• MedTrade Products Limited,
• Integra LifeSciences Corporation,
• Medline Industries, Inc.,
• HEMOTEC MEDICAL GMBH, Stryker,
• CSL Behring,
• Mallinckrodt,
• Equimedical, B.V.
The market is further segmented into:
• Type
• Application
• Usage Pattern
• Mode Administration
• End User
• Geography
The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based hemostats, gelatin based hemostats and collagen based hemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.
Based on application, the market is segmented into surgery and wound closure.
Based on end users, the market is classified into hospitals, community healthcare, ambulatory centers and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Based on geography, the Global Medical Aesthetics market is segmented into 11 geographical regions, such as,
Japan,
• North America,
• South America,
• Europe,
• Asia-Pacific,
• Middle East
• Africa
Covered in this report
The report covers the present scenario and the growth prospects of the Global Medical Aesthetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
The major factors driving the growth of this market are the increasing number of surgeries, increasing healthcare expenditure, technological advancements, chronic condition and aging population.
The key market players for Global Medical Aesthetics Market are listed below:
• Ethicon US LLC (U.S.)
• Pfizer and C.R. Bard Inc.,
• Baxter,
• Vascular Solutions, Inc.,
• B.Braun Melsungen,
• 3-D Matrix, Ltd.,
• Resorba Medical GmbH (an Advanced Medical Solutions Group plc Company)
• , Anika Therapeutics, Inc.,
• Arch Therapeutics Inc.
• , Biom’Up SAS,
• CryoLife, Inc.,
• Gamma Therapeutics, Inc.,
• Hemostasis,
• LLC,
• MedTrade Products Limited,
• Integra LifeSciences Corporation,
• Medline Industries, Inc.,
• HEMOTEC MEDICAL GMBH, Stryker,
• CSL Behring,
• Mallinckrodt,
• Equimedical, B.V.
The market is further segmented into:
• Type
• Application
• Usage Pattern
• Mode Administration
• End User
• Geography
The Global Hemostats Market is segmented on the basis of type, application, distribution channel, and end user. The global hemostats market is segmented into 5 major types, namely thrombin based hemostats, combination agents, oxidized regenerated cellulose based hemostats, gelatin based hemostats and collagen based hemostats. In 2017, the thrombin based hemostats segment is expected to dominate the market with a share of ~38.0% and collagen agents is expected to grow with the highest CAGR during the forecast period from 2017 to 2024.
Based on application, the market is segmented into surgery and wound closure.
Based on end users, the market is classified into hospitals, community healthcare, ambulatory centers and clinics. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.
Based on geography, the Global Medical Aesthetics market is segmented into 11 geographical regions, such as,
Japan,
• North America,
• South America,
• Europe,
• Asia-Pacific,
• Middle East
• Africa
Covered in this report
The report covers the present scenario and the growth prospects of the Global Medical Aesthetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
